| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 01/12/2005 | EP1274680B1 Synthesis intermediate products for producing vitamin d derivatives |
| 01/12/2005 | CN1564800A Method for the preparation of a stable alkali metal lactate in powder form |
| 01/12/2005 | CN1562945A Method for snthesizing isomery polyethenoxy ether carboxylate |
| 01/06/2005 | WO2005000784A2 5-[phenyl, tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl- cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity |
| 01/06/2005 | WO2005000780A1 Piperazine salts of hydroxycinnamic acids and hydroxystilbenes |
| 01/06/2005 | US20050004395 Reacting perfluoroperoxy alcohol with base; heating; hydrolysis: acidification; separation |
| 01/06/2005 | US20050004213 5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050004082 Ether compounds |
| 01/06/2005 | US20050003000 Method for the the formation of ibuprofen crystals |
| 01/05/2005 | EP1493030A2 Charge-balanced chemoselective linkers |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | EP1155138B1 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives |
| 01/05/2005 | CN1561198A Surfactant compounds and uses thereof |
| 01/05/2005 | CN1560017A Process for separating and recovering potash element form Eichhornic crassipes plant |
| 01/05/2005 | CN1560016A Preparation process of malic acid |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/29/2004 | WO2004112774A1 RESOLUTION OF α-(PHENOXY)PHENYLACETIC ACID DERIVATIVES |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | EP1490412A1 Photoinitiator, novel compound, and photocurable composition |
| 12/29/2004 | EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | CN1558909A Supermolecular carboplatinum derivatives, their preparation method, and pharmaceutical composition containing them as active ingredient and applications of the composition |
| 12/29/2004 | CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/29/2004 | CA2529774A1 Resolution of .alpha.-(phenoxy)phenylacetic acid derivatives |
| 12/23/2004 | WO2004110974A1 Matrix metalloproteinase inhibitors |
| 12/23/2004 | WO2003087028A9 A method of making salt |
| 12/23/2004 | US20040260098 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 12/23/2004 | US20040259950 Dicarboxy compounds for use as drugs and receptors for proliferation |
| 12/23/2004 | US20040259938 Novel dipheylenthylene compounds |
| 12/22/2004 | EP1489124A1 (Per)fluoropolyether carboxylic acids and use thereof for the oleo-repellent paper sizing |
| 12/22/2004 | EP1305346B1 Transformation of polymers to useful chemicals by oxidation |
| 12/21/2004 | US6833477 Process for producing a vic-dichloro acid fluoride |
| 12/15/2004 | EP1486203A2 Surfactant compounds and uses thereof |
| 12/15/2004 | EP1485343A1 Amorphous hmg-coa reductase inhibitors of desired particle size |
| 12/15/2004 | CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations |
| 12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
| 12/14/2004 | US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added) |
| 12/14/2004 | US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/14/2004 | US6831102 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia |
| 12/09/2004 | WO2004106276A1 Condensed ring compound |
| 12/09/2004 | WO2004099280A3 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 12/09/2004 | US20040249220 Process for producing optically active 2-alkoxy-1-(trifluoromethyl-substituted phenyl) ethanol derivatives |
| 12/09/2004 | US20040249206 Method for the purification of a-hydroxy acids on an industrial scale |
| 12/09/2004 | US20040248919 Insulin sensitizers which do not increase triglyceride levels or suppress thyroid hormone axis; such as 7-[3,5-di-tert-butyl-2-(2,2-difluoroethoxy)-phenyl]-4-fluoro-3-methyl-octa-2,4,6-trienoic acid; synthesis; retinoid X receptor (rxr) |
| 12/09/2004 | US20040248850 Compounds for the treatment of HIV infection |
| 12/09/2004 | CA2527691A1 Condensed ring compound |
| 12/08/2004 | EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments |
| 12/08/2004 | EP0966420B1 2-arylcyclopentane-1,3-diones |
| 12/08/2004 | CN1552315A 治疗组合物 The therapeutic composition |
| 12/07/2004 | US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis |
| 12/02/2004 | WO2004103946A1 Carboxylic acid compound and medicine containing the same |
| 12/02/2004 | WO2004103074A1 Copper salts of organic acids and use thereof as fungicides |
| 12/02/2004 | WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/02/2004 | US20040242921 Resolution of racemic mixtures using an amine |
| 12/02/2004 | US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 12/02/2004 | US20040242492 Mandelic acid derivatives and their use as thrombin inhibitors |
| 12/02/2004 | US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability |
| 12/02/2004 | CA2526637A1 Carboxylic acid compound and medecine comprising the same |
| 12/01/2004 | EP1481962A1 New cholesterolemia-lowering carboxyalkylether compound |
| 12/01/2004 | EP1481958A1 Production of organic compounds which are low in fluoride |
| 12/01/2004 | CN1551866A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| 12/01/2004 | CN1177808C Solid compositions suitable for oral administration composing L-carnitine and alkanoyl-L-carnitine mangesium tartrate |
| 12/01/2004 | CN1177807C Stable, nno-hygroscopic salts of L(-) carnitine and alkanoyl L(-) carnitinges, process for their preparation and solid, orally administrable compositions containing such salts |
| 11/30/2004 | US6825378 Process for the synthesis of enantiomerically pure cyclohexylphenyl glycolic acid |
| 11/30/2004 | US6825360 Bicyclic aromatic compounds |
| 11/30/2004 | CA2305307C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 11/25/2004 | WO2004073611A3 Compounds for the treatment of metabolic disorders |
| 11/25/2004 | WO2004067489A3 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 11/25/2004 | US20040236148 Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia |
| 11/25/2004 | US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 11/25/2004 | US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease. |
| 11/25/2004 | US20040234556 Aerosol mixture of drug particles in fluorohydrocarbon propellant |
| 11/24/2004 | EP1478640A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 11/24/2004 | EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs |
| 11/24/2004 | CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors |
| 11/24/2004 | CN1548413A Beta-diketoacid as dimer compound and its prepn and use |
| 11/24/2004 | CN1176918C Intermediate of alpha-substituted benzene acetic acid derivate with farm pesticide activity |
| 11/18/2004 | WO2004099280A2 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 11/18/2004 | WO2004099279A2 Heat activated tertiary amine urethane catalysts |
| 11/18/2004 | WO2004098582A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 11/18/2004 | US20040230073 N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L- alpha -aspartyl]-L-phenylalanine-1-methyl ester; sweeteners; purity, yield; industrially profitable |
| 11/18/2004 | US20040230060 Process for preparing 1,5-diaryl-3-substituted pyrazoles |
| 11/18/2004 | US20040229899 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) |
| 11/18/2004 | CA2524267A1 Heat activated tertiary amine urethane catalysts |
| 11/18/2004 | CA2524260A1 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 11/17/2004 | EP1477472A1 Substituted phenylalkanoic acid derivative and use thereof |
| 11/17/2004 | EP1477468A1 Novel process for producing 1,2-diol |
| 11/17/2004 | CN1547566A Spliting method of (r)-(-)-2-hydroxyl-2-(2-chlorphenyl)acetic acid |
| 11/17/2004 | CN1547554A Method for the preparation of lactic acid and calcium sulphate dihydrate |
| 11/17/2004 | CN1546455A Resveratrol oxo acid derivatives, their preparation and pharmaceutical compositions |
| 11/17/2004 | CN1176060C Process for preparing sodium phenyl pyruvate by pressure hydrolyzing benzal hydantoin |
| 11/17/2004 | CN1176059C Quantitative separation of esterified and etherified ferulaic acid and cumaric acid in stalk cell walls |
| 11/16/2004 | US6818423 Process for the preparation of chiral α-hydroxycarboxylic acids |
| 11/11/2004 | WO2004096120A2 Compounds that selectively bind to membranes of apoptotic cells |
| 11/11/2004 | US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 11/10/2004 | EP1261657B1 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof |
| 11/10/2004 | EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE |
| 11/10/2004 | CN1544409A Ferulic acid and ferulate preparation method |
| 11/10/2004 | CN1174953C Process for producing purified lactic acid solution |
| 11/09/2004 | US6815559 Process for producing 3,3,3-trifluoro-2-hydroxypropionic acid or its derivative |